Amundi Stoxx Europe 600 UCITS ETF (LON:MEUS)
London · Delayed Price · Currency is GBP · Price in USD 317.25
-3.08 (-0.96%)
Oct 9, 2025, 4:29 PM BST
-0.96% (1Y)
| Assets | 12.03B |
| Expense Ratio | 0.07% |
| PE Ratio | 15.95 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +20.71% |
| Volume | 7,573 |
| Open | 319.65 |
| Previous Close | 320.33 |
| Day's Range | 317.25 - 320.15 |
| 52-Week Low | 241.00 |
| 52-Week High | 321.65 |
| Beta | 0.77 |
| Holdings | 612 |
| Inception Date | Apr 3, 2013 |
About MEUS
Amundi Stoxx Europe 600 UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS. The fund invests in public equity markets of Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the Stoxx Europe 600 Net Return EUR Index, by investing in the stocks of companies as per their weightings in the index. Amundi Stoxx Europe 600 UCITS ETF was formed on August 2, 2010 and is domiciled in Luxembourg.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol MEUS
Provider Amundi
Index Tracked STOXX Europe 600
Performance
MEUS had a total return of 20.71% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.03%.
Top 10 Holdings
18.56% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.98% |
| SAP SE | SAP | 1.99% |
| AstraZeneca PLC | AZN | 1.91% |
| Novartis AG | NOVN | 1.84% |
| Roche Holding AG | ROG | 1.83% |
| HSBC Holdings plc | HSBA | 1.78% |
| Nestlé S.A. | NESN | 1.73% |
| Shell plc | SHEL | 1.56% |
| Siemens Aktiengesellschaft | SIE | 1.55% |
| Novo Nordisk A/S | NOVO.B | 1.41% |